Best in Biotech 19 Sep 2024 Six immunology biotech companies revolutionizing immune treatments in 2024 Find out more about six immunology companies that have recently raised impressive funds in the biotech industry. September 19, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like. September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 13 Sep 2024 Stealth mode biotech startups: Everything you need to know Discover all you need to know about stealth mode biotech startups, including what stealth mode is and its advantages and disadvantages. September 13, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2024 The biggest private biotech investments in August 2024 The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024. September 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2024 Adaptimmune: The long road toward finally bringing the first TCR-T cell therapy to the market Find out about Adaptimmune’s long – and somewhat bumpy – road toward bringing the first TCR-T therapy to the market. September 3, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases. August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 6 Aug 2024 The biggest private biotech investments in July 2024 The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024. August 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2024 Why is the immunology and inflammation market suddenly attracting a wave of investment? Discover why the immunology and inflammation market has recently been attracting a major wave of investment. July 30, 2024 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Jul 2024 Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market? Find out more about Pfizer’s GLP-1 candidate danuglipron, as the company aims to compete in the obesity market. July 24, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 19 Jul 2024 The ABC of biotech partnerships Discover eight different types of biotech partnerships, including what each one entails and its advantages and disadvantages. July 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2024 Lenacapavir: Can Gilead’s drug end the HIV pandemic? Discover more about Gilead’s lenacapavir, which recently demonstrated 100% efficacy for HIV prevention in a phase 3 trial. July 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email